DK269190A - 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider - Google Patents

3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider Download PDF

Info

Publication number
DK269190A
DK269190A DK269190A DK269190A DK269190A DK 269190 A DK269190 A DK 269190A DK 269190 A DK269190 A DK 269190A DK 269190 A DK269190 A DK 269190A DK 269190 A DK269190 A DK 269190A
Authority
DK
Denmark
Prior art keywords
dioxides
thiadiazol
disubstituted
oxides
Prior art date
Application number
DK269190A
Other languages
English (en)
Other versions
DK164702B (da
DK269190D0 (da
DK164702C (da
Inventor
Ronnie Ray Crenshaw
Aldo Antonio Algieri
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK269190A publication Critical patent/DK269190A/da
Publication of DK269190D0 publication Critical patent/DK269190D0/da
Publication of DK164702B publication Critical patent/DK164702B/da
Application granted granted Critical
Publication of DK164702C publication Critical patent/DK164702C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
DK269190A 1979-09-04 1990-11-09 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider DK164702C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US7251779A 1979-09-04 1979-09-04
US7251779 1979-09-04
US11718280A 1980-01-31 1980-01-31
US11718280 1980-01-31
US16383180A 1980-06-07 1980-06-07
US16383180 1980-06-07

Publications (4)

Publication Number Publication Date
DK269190A true DK269190A (da) 1990-11-09
DK269190D0 DK269190D0 (da) 1990-11-09
DK164702B DK164702B (da) 1992-08-03
DK164702C DK164702C (da) 1992-12-21

Family

ID=27372107

Family Applications (4)

Application Number Title Priority Date Filing Date
DK371880A DK160611C (da) 1979-09-04 1980-09-01 Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DK268990A DK164363C (da) 1979-09-04 1990-11-09 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider
DK269090A DK164700C (da) 1979-09-04 1990-11-09 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider
DK269190A DK164702C (da) 1979-09-04 1990-11-09 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK371880A DK160611C (da) 1979-09-04 1980-09-01 Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DK268990A DK164363C (da) 1979-09-04 1990-11-09 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider
DK269090A DK164700C (da) 1979-09-04 1990-11-09 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider

Country Status (23)

Country Link
US (1) US4374248A (da)
AR (1) AR240559A1 (da)
AT (2) AT376978B (da)
CA (4) CA1167841A (da)
CH (2) CH649764A5 (da)
CS (1) CS235951B2 (da)
CY (2) CY1360A (da)
DE (2) DE3051146C2 (da)
DK (4) DK160611C (da)
FI (1) FI76795C (da)
GB (2) GB2067987B (da)
HK (2) HK41387A (da)
IE (2) IE50997B1 (da)
KE (2) KE3685A (da)
LU (1) LU82753A1 (da)
MY (2) MY8700585A (da)
NL (3) NL189197C (da)
NO (4) NO160003C (da)
NZ (1) NZ194831A (da)
PT (1) PT71764B (da)
SE (5) SE449099B (da)
SG (1) SG61187G (da)
ZW (1) ZW20580A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4471122A (en) * 1981-03-03 1984-09-11 Bristol-Myers Company Thiadiazole histamine H2 -antagonists
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
DE3271253D1 (en) * 1981-08-24 1986-06-26 Merck & Co Inc Thiadiazole oxides as gastric antisecretory agents
GR77847B (da) * 1981-12-14 1984-09-25 American Home Prod
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4578471A (en) * 1982-03-29 1986-03-25 Bristol-Myers Company Substituted amino alkyl pyridyl ethanediimidamides
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
ES520982A0 (es) * 1982-03-29 1984-05-16 Bristol Myers Co Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
EP0105732A3 (en) * 1982-10-01 1985-09-04 Beecham Group Plc Histamine h2 receptor antagonists of the benzisothiazole amino and benzthiadiazine amino series
US4461900A (en) * 1983-03-14 1984-07-24 American Home Products Corporation 4,5-Dihydrothiadiazole 1,1-dioxide derivatives
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles
AT387384B (de) * 1983-03-16 1989-01-10 Bristol Myers Co Verfahren zur herstellung von thiadiazolderivaten
EP0123741A1 (en) * 1983-04-26 1984-11-07 Shionogi & Co., Ltd. 2-Guanidino-4-hydroxymethylthiazole and derivatives thereof
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
DE3326545A1 (de) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4529731A (en) * 1983-09-22 1985-07-16 American Home Products Corporation Thiadiazolediamine derivative with histamine H-2 receptor inhibiting properties
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4692531A (en) * 1984-06-22 1987-09-08 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4612309A (en) * 1984-10-23 1986-09-16 William H. Rorer, Inc. Antisecretory bicyclic benzo-oxy heterocyclic ethers and thioethers
GB8501535D0 (en) * 1985-01-22 1985-02-20 Smith Kline French Lab Chemical compounds
US4728648A (en) * 1985-02-09 1988-03-01 Smith Kline & French Laboratories Limited Histamine antagonist triadiazole derivatives, compositions, and method of use therefor
GB8509276D0 (en) * 1985-04-11 1985-05-15 Smith Kline French Lab Pyridine derivatives
GB8510680D0 (en) * 1985-04-26 1985-06-05 Smith Kline French Lab Pyridine derivatives
CA1286297C (en) * 1985-06-13 1991-07-16 George S. Sach Pyridine derivatives
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
GB8610867D0 (en) * 1986-05-02 1986-06-11 Smith Kline French Lab 3-hydroxypyridines
ES2008962A6 (es) * 1987-12-17 1989-08-16 Marga Investigacion Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
ES2151480T3 (es) * 1991-05-21 2001-01-01 Lilly Co Eli Procedimiento para preparar productos intermedios de nizatidina y compuestos relacionados.
US5248673A (en) * 1992-12-23 1993-09-28 Bristol-Myers Squibb Co. Bisamidine derivatives as thrombin inhibitors
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
US5767280A (en) * 1995-06-01 1998-06-16 Eli Lilly And Company Process for making heterocyclic compounds
MXPA05003867A (es) 2002-10-09 2005-11-23 Schering Corp Tiadiazoldioxidos y tiadiazoloxidos como ligandos de receptor cxc-y cc-quimiocina.
EP1694659B8 (en) 2003-12-19 2008-10-08 Schering Corporation Thiadiazoles as cxc- and cc- chemokine receptor ligands
CN1918156B (zh) 2003-12-22 2010-10-27 先灵公司 作为cxc-和cc-趋化因子受体配体的异噻唑二氧化物
JP2009500334A (ja) 2005-06-29 2009-01-08 シェーリング コーポレイション Ｃｘｃ−ケモカインレセプターリガンドとしてのジ置換オキサジアゾール
ATE486078T1 (de) 2005-06-29 2010-11-15 Schering Corp 5,6-disubstituierte oxadiazolopyrazine und thiadiazolopyrazine als liganden des cxc- chemokinrezeptors
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
WO2014009293A1 (en) 2012-07-13 2014-01-16 Basf Se New substituted thiadiazoles and their use as fungicides
SG11201504622PA (en) 2012-12-20 2015-07-30 Inception 2 Inc Triazolone compounds and uses thereof
CN105579440A (zh) 2013-09-06 2016-05-11 因森普深2公司 三唑酮化合物及其应用
CN105061360B (zh) * 2015-07-28 2018-06-19 首都师范大学 一种3,4-二氨基-1,2,5-噻二唑的提纯方法
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL22850A (en) * 1964-03-18 1968-12-26 Merck & Co Inc 3-chloro-1,2,5-thiazdiazole-4-carboxylic acid being an intermediate in the preparation of sulfa drugs
CH482712A (de) * 1964-10-01 1969-12-15 Merck & Co Inc Verfahren zur Herstellung von 3-Amino-1,2,5-thiadiazolen
US3419573A (en) * 1965-10-15 1968-12-31 Merck & Co Inc 3-chloro-4-oxy-1,2,5-thiadiazoles, and a process for preparing same
US3564000A (en) * 1965-10-15 1971-02-16 Merck & Co Inc Process for preparing 3-chloro-4-hydroxy-1,2,5-thiadiazole derivatives
DE1770152A1 (de) * 1968-04-08 1971-09-30 Lentia Gmbh Verfahren zur Herstellung von 3-Amino-4-brom-1,2,5-thiadiazol
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
US4104381A (en) * 1973-05-03 1978-08-01 Smith Kline & French Laboratories Limited Pharmacologically active compounds
AT348517B (de) * 1977-01-19 1979-02-26 Chemie Linz Ag Verfahren zur herstellung von reinem 3-methoxy- 4- (4'-aminobenzolsulfonamido) -1,2,5-thiadiazol
GR62452B (en) * 1977-04-20 1979-04-12 Ici Ltd Preparation process of guanidine derivatives
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
DE3271253D1 (en) * 1981-08-24 1986-06-26 Merck & Co Inc Thiadiazole oxides as gastric antisecretory agents

Also Published As

Publication number Publication date
AT377257B (de) 1985-02-25
FI802740A (fi) 1981-03-05
NL189197C (nl) 1993-02-01
NL8004967A (nl) 1981-03-06
NO871421D0 (no) 1987-04-06
SE8403107L (sv) 1984-06-08
DE3033169A1 (de) 1981-03-19
KE3685A (en) 1987-01-30
NO871420D0 (no) 1987-04-06
SE449099B (sv) 1987-04-06
SE8403111D0 (sv) 1984-06-08
CA1263114A (en) 1989-11-21
FI76795C (fi) 1988-12-12
DK268990A (da) 1990-11-09
DK269090D0 (da) 1990-11-09
DK269090A (da) 1990-11-09
SE8403108L (sv) 1984-06-08
PT71764A (en) 1980-09-30
GB2067987B (en) 1984-07-11
FI76795B (fi) 1988-08-31
ATA443480A (de) 1984-06-15
DK160611C (da) 1991-09-16
DE3033169C2 (de) 1989-08-03
DE3051146C2 (de) 1991-05-02
SE456580B (sv) 1988-10-17
NO162664B (no) 1989-10-23
DK371880A (da) 1981-03-05
AR240559A1 (es) 1990-05-31
SE8006148L (sv) 1981-04-15
CA1248962A (en) 1989-01-17
NO862501D0 (no) 1986-06-23
NO161737C (no) 1989-09-20
IE861175L (en) 1981-03-04
KE3742A (en) 1987-09-04
DK160611B (da) 1991-04-02
GB2132190A (en) 1984-07-04
NL9201236A (nl) 1993-03-01
GB2067987A (en) 1981-08-05
US4374248A (en) 1983-02-15
SE456582B (sv) 1988-10-17
HK89187A (en) 1987-12-11
DK164702B (da) 1992-08-03
NO160003C (no) 1989-03-01
ATA64584A (de) 1984-07-15
CH649764A5 (de) 1985-06-14
DK269190D0 (da) 1990-11-09
AT376978B (de) 1985-01-25
IE51235B1 (en) 1986-11-12
DK164363C (da) 1992-11-02
HK41387A (en) 1987-06-05
DK268990D0 (da) 1990-11-09
IE801851L (en) 1981-03-04
MY8700585A (en) 1987-12-31
NL9201237A (nl) 1993-03-01
NO160781B (no) 1989-02-20
GB2132190B (en) 1985-01-03
NL189197B (nl) 1992-09-01
CA1167841A (en) 1984-05-22
CH658055A5 (de) 1986-10-15
SE8403111L (sv) 1984-06-08
NO160003B (no) 1988-11-21
GB8318949D0 (en) 1983-08-17
MY8700735A (en) 1987-12-31
SE8403108D0 (sv) 1984-06-08
SE461733B (sv) 1990-03-19
CY1360A (en) 1987-08-07
SE8403109D0 (sv) 1984-06-08
DK164700C (da) 1992-12-21
NO161737B (no) 1989-06-12
NO162664C (no) 1990-01-31
NO802576L (no) 1981-03-05
NO862501L (no) 1987-03-05
NZ194831A (en) 1984-11-09
DK164363B (da) 1992-06-15
CY1402A (en) 1987-12-18
CS235951B2 (en) 1985-05-15
SE8403109L (sv) 1984-06-08
DK164700B (da) 1992-08-03
SE8403107D0 (sv) 1984-06-08
SE456581B (sv) 1988-10-17
NO160781C (no) 1989-05-31
IE50997B1 (en) 1986-09-03
SG61187G (en) 1987-10-23
LU82753A1 (fr) 1981-04-17
CA1263115A (en) 1989-11-21
PT71764B (en) 1983-04-28
DK164702C (da) 1992-12-21
ZW20580A1 (en) 1981-01-21

Similar Documents

Publication Publication Date Title
DK164700C (da) 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider
DK537780A (da) 1,8-naphthyridin-derivater
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
DK3881A (da) Substituerede 9,10-anthracen-bishydrazoner
FI793663A (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
SE7803411L (sv) 2,6-dialkoxibensamider
DE3175317D1 (de) 5-(2,6-dichloro-4-trifluoromethyl-phenoxy)-2-nitrobenzaldehyde-diacetacylal
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
FI803727L (fi) 2,3-indolidionderivat
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
FI801473A (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
BE883295A (fr) 6,7-secoergolines
FI800736A (fi) 1,1'-difenyl-2-yl-alkylaminderivat
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
FI803038A (fi) Framstaellning av 2,5-diketoglukonsyra
FI800106A (fi) Foerfarande foer separering av d,1 2-(6-metoxi-2-naftyl)propionsyra
FI791080A (fi) 4,6-dihalo-steroider
FI803041A (fi) Framstaellning av 2-oxo-dihydrobenso/d/1,3/oxaziner
DK430479A (da) 2,6-dihalogenbensylestere
IT1096332B (it) 1,2,4-triazolidin-3-oni e-tioni fungicidi
SE7604521L (sv) 1,2,4-bensotiadiazin-1,1-dioxid-derivat
DE2953592A1 (de) 24,24-difluoro-25-hydroxycholecalciferol
NO802405L (no) 2-sulfinyl-5-sulfonyl-1,3,4-thiadiazolderivater
DK446582A (da) 24,24-difluor-1alfa,15-dihydro-5,6-transcholecalciferol

Legal Events

Date Code Title Description
PBP Patent lapsed